Recurrent breast carcinoma presenting as postmenopausal vaginal bleeding: A case report

Area of Science:

• Oncology
• Gynecologic Oncology
• Pharmacology

Background:

• Postmenopausal vaginal bleeding is a common gynecologic concern.
• Tamoxifen is a widely used medication for breast cancer treatment and prevention.
• Recurrent breast cancer can present with varied and sometimes unusual symptoms.

Purpose of the Study:

• To report a case of breast carcinoma recurrence presenting as postmenopausal vaginal bleeding in a patient on Tamoxifen therapy.
• To illustrate the potential for widespread genital tract involvement in recurrent breast cancer.
• To emphasize the importance of considering gynecologic malignancies in the differential diagnosis of postmenopausal bleeding.

Main Methods:

• Case report presentation.
• Review of patient's clinical history, treatment, and diagnostic workup.
• Discussion of the clinical implications and diagnostic considerations.

Main Results:

• The patient on Tamoxifen therapy presented with postmenopausal vaginal bleeding.
• The bleeding was indicative of widespread genital tract manifestation of recurrent breast carcinoma.
• The disease exhibited rapid progression.

Conclusions:

• Postmenopausal vaginal bleeding can be an atypical presentation of recurrent breast carcinoma in patients treated with Tamoxifen.
• A broad differential diagnosis, including gynecologic spread of malignancy, is crucial for timely and accurate diagnosis.
• Early recognition and management are vital due to the potential for rapid disease progression.